CELL SIGNALING TECHNOLOGY
Live / Registered — Registered and renewed (as of 18 Oct 2021)
What this means for you
Registered since 30 Aug 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Aug 2021).
Record
- Serial number
- 77907992
- Registration number
- 4017621
- Mark type
- Design + words
- Filed
- 08 Jan 2010
- Published for opposition
- 14 Jun 2011
- Registered
- 30 Aug 2011
- Next maintenance due
- 30 Aug 2021
- Attorney of record
- Keith A. Weltsch, Esq.
Goods and services
- Class 001 — Chemicals: Reagents for scientific or medical research use, namely, antibodies for the detection of signaling molecules, post-translational modifications on signaling molecules, non-radioactive kinase and other enzyme assays, kinase and other enzyme inhibitors
Owner
- Cell Signaling Technology, Inc., Danvers, MA, US
- Cell Signaling Technology, Inc., Danvers, MA, US
- Cell Signaling Technology, Inc., Danvers, MA, US
Prior registrations
Prosecution history
- 13 Dec 2022 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 10 Nov 2022 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 07 Nov 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Jun 2022 — TEAS SECTION 7 REQUEST RECEIVED
- 08 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 18 Oct 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 18 Oct 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Oct 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Jun 2021 — TEAS SECTION 8 & 9 RECEIVED
- 06 Mar 2021 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 11 Dec 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Sept 2020 — TEAS SECTION 7 REQUEST RECEIVED